Nxera Pharma Co., Ltd. (TYO:4565)
857.00
-11.00 (-1.27%)
Jul 18, 2025, 3:30 PM JST
Nxera Pharma Employees
Nxera Pharma had 374 employees as of December 31, 2024. The number of employees increased by 24 or 6.86% compared to the previous year.
Employees
374
Change (1Y)
24
Growth (1Y)
6.86%
Revenue / Employee
79.76M JPY
Profits / Employee
-5.99M JPY
Market Cap
77.05B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 5,026 |
Takeda Pharmaceutical Company | 47,455 |
Daiichi Sankyo Company | 19,765 |
HOYA Corporation | 37,909 |
Otsuka Holdings | 35,338 |
Astellas Pharma | 13,643 |
Shionogi & | 4,955 |
Olympus | 29,297 |
Nxera Pharma News
- 16 days ago - Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa's Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist - GlobeNewsWire
- 6 weeks ago - Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568 - GlobeNewsWire
- 6 weeks ago - Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases - GlobeNewsWire
- 7 weeks ago - Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025 - GlobeNewsWire
- 2 months ago - Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025 - GlobeNewsWire
- 2 months ago - Nxera Pharma's Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia - GlobeNewsWire
- 2 months ago - Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations - GlobeNewsWire
- 3 months ago - Nxera Pharma Announces Appointments to its Executive Leadership Team - GlobeNewsWire